Follow the 富士莱 share price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 富士莱 has logged 3 reports. Market capitalisation: €2.3bn. The latest transaction was disclosed on 1 June 2026 (Sale). Among the most active insiders: 钱怡. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
富士莱 es una empresa que opera en el sector de la salud y la farmacia, cotiza en el mercado XSHE. Se especializa en el desarrollo y la distribución de productos farmacéuticos.